{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T19:20:11Z","timestamp":1789672811511,"version":"4.0.1"},"reference-count":37,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["mgmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.ymgme.2017.04.014","type":"journal-article","created":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T02:01:01Z","timestamp":1493604061000},"page":"127-137","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["Cognitive and academic outcomes in long-term survivors of infantile-onset Pompe disease: A longitudinal follow-up"],"prefix":"10.1016","volume":"121","author":[{"given":"Gail A.","family":"Spiridigliozzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lori A.","family":"Keeling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihaela","family":"Stefanescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cindy","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Austin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priya S.","family":"Kishnani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 1","key":"10.1016\/j.ymgme.2017.04.014_bb0005","first-page":"114","article-title":"New therapeutic approaches for Pompe disease: enzyme replacement therapy and beyond","volume":"12","author":"Kishnani","year":"2014","journal-title":"Pediatr. Endocrinol. Rev."},{"key":"10.1016\/j.ymgme.2017.04.014_bb0010","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1212\/01.wnl.0000251268.41188.04","article-title":"Recombinant human acid [alpha]-glucosidase: major clinical benefits in infantile-onset Pompe disease","volume":"68","author":"Kishnani","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.ymgme.2017.04.014_bb0015","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.ymgme.2011.10.012","article-title":"Early cognitive development in children with infantile Pompe disease","volume":"105","author":"Spiridigliozzi","year":"2012","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2017.04.014_bb0020","series-title":"Bayley Scales of Infant Development","author":"Bayley","year":"1993"},{"key":"10.1016\/j.ymgme.2017.04.014_bb0025","series-title":"Motor Assessment of the Developing Infant: Alberta Infant Motor Scale","author":"Piper","year":"1994"},{"key":"10.1016\/j.ymgme.2017.04.014_bb0030","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1177\/0883073816665549","article-title":"Cognitive development in infantile-onset Pompe disease under very early enzyme replacement therapy","volume":"31","author":"Lai","year":"2016","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.ymgme.2017.04.014_bb0035","series-title":"Bayley Scales of Infant and Toddler Development","author":"Bayley","year":"2006"},{"key":"10.1016\/j.ymgme.2017.04.014_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpeds.2015.10.078","article-title":"Very early treatment for infantile-onset Pompe disease contributes to better outcomes","volume":"169","author":"Yang","year":"2016","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2017.04.014_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpeds.2014.10.068","article-title":"Long-term prognosis of patients with infantile-onset Pompe disease diagnosed by newborn screening and treated since birth","volume":"166","author":"Chien","year":"2015","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2017.04.014_bb0050","series-title":"Peabody Developmental Motor Scales","author":"Folio","year":"2000"},{"key":"10.1016\/j.ymgme.2017.04.014_bb0055","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/ajmg.c.31323","article-title":"Cognitive and adaptive functioning of children with infantile Pompe disease treated with enzyme replacement therapy: long-term follow-up","volume":"160C","author":"Spiridigliozzi","year":"2012","journal-title":"Am. J. Med. Genet. C Semin. Med. Genet."},{"key":"10.1016\/j.ymgme.2017.04.014_bb0060","series-title":"Wechsler Preschool and Primary Scale of Intelligence","author":"Wechsler","year":"2002"},{"key":"10.1016\/j.ymgme.2017.04.014_bb0065","series-title":"Wechsler Intelligence Scale for Children - Fourth Edition","author":"Wechsler","year":"2003"},{"key":"10.1016\/j.ymgme.2017.04.014_bb0070","series-title":"Vineland Adaptive Behavior Scales","author":"Sparrow","year":"2005"},{"key":"10.1016\/j.ymgme.2017.04.014_bb0075","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1212\/WNL.0b013e3182553c11","article-title":"Cognitive outcome of patients with classic infantile Pompe disease receiving enzyme therapy","volume":"78","author":"Ebbink","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.ymgme.2017.04.014_bb0080","series-title":"Snijders Oomen Nonverbal Intelligence Test - Revised","author":"Tellegen","year":"2008"},{"key":"10.1016\/j.ymgme.2017.04.014_bb0085","series-title":"The Abilities of Young Children","author":"Griffiths","year":"1984"},{"key":"10.1016\/j.ymgme.2017.04.014_bb0090","series-title":"The Abilities of Babies","author":"Griffiths","year":"1986"},{"key":"10.1016\/j.ymgme.2017.04.014_bb0095","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1212\/WNL.0000000000002523","article-title":"Cognitive decline in classic infantile Pompe disease: an underacknowledged challenge","volume":"86","author":"Ebbink","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.ymgme.2017.04.014_bb0100","first-page":"135","article-title":"Successful immune tolerance induction to enzyme replacement therapy in CRIM-negative infantile Pompe disease","volume":"14","author":"Messinger","year":"2012","journal-title":"Genet. Med. Off. J. Am. Coll. Med. Genet."},{"issue":"Suppl. 1","key":"10.1016\/j.ymgme.2017.04.014_bb0105","first-page":"S52","article-title":"The emerging neurocognitive profile of classic infantile Pompe disease","volume":"39","author":"Ebbink","year":"2016","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2017.04.014_bb0110","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1016\/j.ymgme.2015.12.185","article-title":"Neuroimaging findings in infantile Pompe patients treated with enzyme replacement therapy","volume":"117","author":"Austin","year":"2016","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2017.04.014_bb0115","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/s10545-010-9209-0","article-title":"CRIM-negative infantile Pompe disease: 42-month treatment outcome","volume":"33","author":"Rohrbach","year":"2010","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2017.04.014_bb0120","series-title":"Wechsler Preschool and Primary Scale of Intelligence - Fourth Edition","author":"Wechsler","year":"2012"},{"key":"10.1016\/j.ymgme.2017.04.014_bb0125","series-title":"Wechsler Intelligence Scale for Children - Fifth Edition Administration and Scoring Manual With Supplement","author":"Wechsler","year":"2014"},{"key":"10.1016\/j.ymgme.2017.04.014_bb0130","series-title":"Wechsler Adult Intelligence Scale","author":"Wechsler","year":"2008"},{"key":"10.1016\/j.ymgme.2017.04.014_bb0135","series-title":"Leiter International Performance Scale - Revised","author":"Roid","year":"1997"},{"key":"10.1016\/j.ymgme.2017.04.014_bb0140","series-title":"Leiter International Performance Scale","author":"Roid","year":"2013"},{"key":"10.1016\/j.ymgme.2017.04.014_bb0145","series-title":"Woodcock-Johnson III Tests of Achievement","author":"Woodcock","year":"2001"},{"key":"10.1016\/j.ymgme.2017.04.014_bb0150","series-title":"Woodcock-Johnson IV Tests of Achievement","author":"Schrank","year":"2014"},{"key":"10.1016\/j.ymgme.2017.04.014_bb0155","author":"Beery","year":"2006"},{"key":"10.1016\/j.ymgme.2017.04.014_bb0160","author":"Beery","year":"2010"},{"key":"10.1016\/j.ymgme.2017.04.014_bb0165","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1203\/01.pdr.0000233014.84318.4e","article-title":"Brain development in infantile-onset Pompe disease treated by enzyme replacement therapy","volume":"60","author":"Chien","year":"2006","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.ymgme.2017.04.014_bb0170","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.rcl.2013.11.008","article-title":"Imaging manifestations of the leukodystrophies, inherited disorders of white matter","volume":"52","author":"Yang","year":"2014","journal-title":"Radiol. Clin. N. Am."},{"key":"10.1016\/j.ymgme.2017.04.014_bb0175","doi-asserted-by":"crossref","first-page":"W315","DOI":"10.2214\/AJR.13.11154","article-title":"Inborn errors of metabolism: combining clinical and radiologic clues to solve the mystery","volume":"203","author":"Ibrahim","year":"2014","journal-title":"AJR Am. J. Roentgenol."},{"key":"10.1016\/j.ymgme.2017.04.014_bb0180","doi-asserted-by":"crossref","DOI":"10.1017\/S0140525X07001185","article-title":"The Parieto-Frontal Integration Theory (P-FIT) of intelligence: converging neuroimaging evidence","volume":"30","author":"Jung","year":"2007","journal-title":"Behav. Brain Sci."},{"key":"10.1016\/j.ymgme.2017.04.014_bb0185","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.tins.2008.04.001","article-title":"White matter in learning, cognition and psychiatric disorders","volume":"31","author":"Fields","year":"2008","journal-title":"Trends Neurosci."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719217302342?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719217302342?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,2]],"date-time":"2018-09-02T02:30:39Z","timestamp":1535855439000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719217302342"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["S1096719217302342"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2017.04.014","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cognitive and academic outcomes in long-term survivors of infantile-onset Pompe disease: A longitudinal follow-up","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2017.04.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}